Central Nervous System Disorders

EVOTEC TO PRESENT EVOlution TECHNOLOGY PLATFORM AT ISMC-2008

Published in Genetics and Environmental Business Week, September 11th, 2008

Evotec AG (Frankfurt Stock Exchange: EVT; NASDAQ: EVTC), a leading provider in the discovery and development of novel small molecule drugs, announce that they will be speaking at the XXth International Symposium on Medicinal Chemistry held in Vienna, Austria from 31st August to 4th September 2008.

Evotec will be speaking on Monday 1st September at 16.50 (CET) leading the presentation sessions on Fragment Based Drug Discovery. Dr. John Barker, Group Leader of Structural Biology, will front the presentation about the design and implementation of EVOlution™, Evotec's fragment-based drug discovery platform (FBDD). This technology offers an innovative approach for...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Genetics and Environmental Business Week

Source: Genetics and Environmental Business Week (2008-09-11)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry